Shire Settles Suit With Actavis to Delay Intuniv Copy

Shire Plc agreed to a legal settlement preventing Actavis Inc. from introducing a low-cost copy of Shire’s Intuniv drug for attention-deficit hyperactivity disorder until December 2014.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.